The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques
- PMID: 4039227
- DOI: 10.1093/carcin/6.4.561
The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques
Abstract
With polyclonal antibodies raised against cis-Pt(NH3)2Guo-GMP, small quantities of specific Pt-adducts could be detected in DNA from Chinese hamster ovary (CHO) cells treated with the antitumor agent cisplatin, after the DNA had been digested with nucleases and the degradation products separated by anion-exchange chromatography (FPLC). Directly after treatment with 83 microM cisplatin, resulting in 97 X 10(-6) platinum atoms bound per nucleotide, 35.9 +/- 4.7% of the platinum was recovered as cis-Pt(NH3)2d(pGpG), derived from intrastrand cross-links on two neighboring guanines, 3.1 +/- 1.6% as cis-Pt(NH3)2d(GMP)2, the degradation product of interstrand cross-links on two guanines (0.07%, according to separate studies) and of intrastrand cross-links on two guanines separated by one or more bases. The immunochemical method was not sensitive enough for the detection of monofunctionally bound platinum on guanine residues. The amount of these adducts, present in the digests as Pt(NH3)3dGMP, could be established with atomic absorption spectroscopy (AAS) (38.5% of the total Pt-content of the DNA). After a post-treatment incubation of the cells for 24 h, the total amount of platinum decreased to 59 X 10(-6) atoms per nucleotide, indicating the removal of adducts. In the digests, cis-Pt(NH3)2d(pGpG) accounted for 46.4 +/- 6.8% of the total Pt-content, cis-Pt(NH3)2d(GMP)2 for 3.0 +/- 0.9% (0.34% derived from DNA interstrand cross-links). The amounts of monofunctional adducts had decreased to such an extent that the exact quantities (below 15%) could not be determined. According to AAS-assays, at the elution position of cis-Pt(NH3)2d(pApG) a significant amount of Pt-product was present, both at t = 0 and 24 h, but the signals did not allow quantitative evaluation (however, below 48% and 28%, respectively). The possible role of the individual lesions in the DNA in the biological effects of this platinum compound in CHO cells is discussed.
Similar articles
-
Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.Biochemistry. 1985 Jan 29;24(3):707-13. doi: 10.1021/bi00324a025. Biochemistry. 1985. PMID: 4039603
-
Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells.Biochemistry. 1995 Jul 4;34(26):8474-80. doi: 10.1021/bi00026a031. Biochemistry. 1995. PMID: 7599137
-
The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.Br J Cancer. 1990 Jan;61(1):79-82. doi: 10.1038/bjc.1990.18. Br J Cancer. 1990. PMID: 2153398 Free PMC article.
-
Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.Met Ions Biol Syst. 1996;33:105-41. Met Ions Biol Syst. 1996. PMID: 8742842 Review.
-
Cisplatin: synthesis, antitumour activity and mechanism of action.Pharm Weekbl Sci. 1985 Oct 25;7(5):173-80. doi: 10.1007/BF02307573. Pharm Weekbl Sci. 1985. PMID: 3906559 Review.
Cited by
-
Human exonuclease 5 is a novel sliding exonuclease required for genome stability.J Biol Chem. 2012 Dec 14;287(51):42773-83. doi: 10.1074/jbc.M112.422444. Epub 2012 Oct 24. J Biol Chem. 2012. PMID: 23095756 Free PMC article.
-
Human DNA adduct measurements: state of the art.Environ Health Perspect. 1996 Oct;104 Suppl 5(Suppl 5):883-93. doi: 10.1289/ehp.96104s5883. Environ Health Perspect. 1996. PMID: 8933030 Free PMC article. Review.
-
Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy.Proc Natl Acad Sci U S A. 1987 Jul;84(14):5024-8. doi: 10.1073/pnas.84.14.5024. Proc Natl Acad Sci U S A. 1987. PMID: 3110781 Free PMC article.
-
Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives.Int J Mol Sci. 2022 Dec 6;23(23):15410. doi: 10.3390/ijms232315410. Int J Mol Sci. 2022. PMID: 36499737 Free PMC article. Review.
-
On the discovery, biological effects, and use of Cisplatin and metallocenes in anticancer chemotherapy.Bioinorg Chem Appl. 2012;2012:140284. doi: 10.1155/2012/140284. Epub 2012 Jul 12. Bioinorg Chem Appl. 2012. PMID: 22844263 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources